The relationship of glycosylation and isoelectric point with tumor accumulation of avidin

Journal of Nuclear Medicine

Volumn 40, Issue 3, 1999, Pages 479-483

  Yao, Zhengsheng ^a,b   Zhang, Meili ^a   Sakahara, Harumi ^a   Nakamoto, Yuji ^a   Higashi, Tatsuya ^a   Zhao, Songji ^a   Sato, Noriko ^a   Arano, Yasushi ^a   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Avidin modification; Glycosylation; Isoelectric point; Tumor accumulation

Indexed keywords

AVIDIN; BIOTIN; DODECYL SULFATE SODIUM; INDIUM 111; PENTETATE INDIUM IN 111;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; ISOELECTRIC POINT; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALS; AVIDIN; COLONIC NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSYLATION; HUMANS; HYDROGEN-ION CONCENTRATION; INDIUM RADIOISOTOPES; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0033027633     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lacy JH, Wieman TJ, Shively EH. Management of malignant ascites. Surg Gynecol Obstet. 1984;159:397-412.
2. 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies. Cancer Res. 1990;50(suppl):989s-992s.
3. Muto MG, Finkler NJ, Kassis AI, et al. Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125. Gynecol Oncol. 1992;45:265-272.
4. Stewart JSW, Hird V, Snook D, et al. Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer. J Clin Oncol. 1990;8:1941-1950.
5. Hird V, Maraveyas A, Snook D, et al. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br J Cancer. 1993;68:403-406.
6. Stoldt HS, Aftab F, Chinol M, et al. Pretargeting strategies for radioimmunoguided tumour localization and therapy. Eur J Cancer. 1997;33:186-192.
7. Magnani P, Paganelli G, Modorati G, et al. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma. J Nucl Med 1996;37:967-971.
8. Zhang M, Yao Z, Saga T, et al. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody. J Nucl Med. 1998;39:30-33.
9. Zhang M, Yao Z, Sakahara H, et al. Effect of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting. Nucl Med Biol. 1998;25:101-105.
10. Paganelli G, Stell M, Zito F, et al. Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med. 1994;35:1970-1975.
11. Kobayashi H, Sakahara H, Hosono M, et al. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor. J Nucl Med. 1994;35:1677-1684.
12. Yao Z, Zhang M, Kobayashi H, et al. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase. J Nucl Med. 1995;36:837-841.
13. Zhang M, Yao Z, Sakahara H, et al. Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody. Nucl Med Biol. 1997;24:61-64.
14. Yao Z, Zhang M, Sakahara H, Saga T, Arano Y, Konishi J. Avidin targeting of intraperitoneal tumor xenografts. J Natl Cancer Inst. 1998;90:25-29.
15. Rosebrough SF, Hartley DF. Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis. J Nucl Med. 1996;37:1380-1384.
16. Jeong JM, Kinuya S, Paik CH, et al. Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution. Nucl Med Biol. 1994;21:935-940.
17. Bayer EA, Ehrlich-Rogozinski S, Wilchek M. Sodium dodecyl sulfate-polyacrylamide gel electrophoretic method for assessing the quaternary state and comparative thermostability of avidin and streptavidin. Electrophoresis. 1996; 17:1319-1324.
18. Rosebrough SF. Pharmacokinetics and biodistribution of radiolabeled avidin. streptavidin and biotin. Nucl Med Biol. 1993;20:663-668.
19. Pardridge WM, Kang YS, Yang J, Buciak JL. Enhanced cellular uptake and in vivo biodistribution of a monoclonal antibody following canonization. J Pharm Sci. 1995;84:943-948.
20. Kumagai AK, Eisenberg JB, Pardridge WM. Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. J Biol Chem. 1987;262:15214-15219.
21. Triguero D, Buciak JL, Yang J, Pardridge WM. Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci USA. 1989;86:4761-4765.
22. Triguero D, Buciak JL, Pardridge WM. Calionization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate. J Pharmacol Exp Ther. 1991;258:186-192.
23. Pardridge WM, Bickel U, Buciak J, Yang J, Diagne A, Aepinus C. Cationization of a monoclonal antibody to the human immunodeficiency virus REV protein enhances cellular uptake but does not impair antigen binding of the antibody. Immunol Lett. 1994;42:191-195.
24. Townsend R, Stahl P. Isolation and characterization of a mannose/N-acetylglucosamine/fucose-binding protein from rat liver. Biochem J. 1981;194:209-214.
25. Hiller Y, Gershoni JM, Bayer EA, Wilchek M. Biotin binding to avidin. Oligosaccharide side chain not required for ligand association. Biochem J. 1987;248:167-171.
26. Yao Z, Zhang M, Sakahara H, et al. Imaging of intraperitoneal tumor with technetium-99m GSA. Ann Nucl Med. 1998;12:115-118.
27. Schechter B, Silberman R, Arnon R, Wilchek M. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin. Eur J Biochem. 1990;189:327-331.
28. Mattes MJ. Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications. J Natl Cancer Inst. 1987;79: 855-863.
29. Lotan R, Raz A. Lectins in cancer cells. Ann N Y Acad Sci. 1988;551:385-398.
30. Monsigny M, Roche AC, Midoux P. Endogenous lectins and drug targeting. Ann N Y Acad Sci. 1988;551:399-414.
31. Gabius HJ, Engelhardt R, Cramer F. Endogenous tumor lectins: overview and perspectives. Anticancer Res. 1986;6:573-578.
32. Ohannesian DW, Lotan D, Thomas P, et al. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res. 1995;55:2191-2199.
33. Wadhwa MS, Rice KG. Receptor mediated glycotargeting. J Drug Target. 1995;3:111-127.
34. Paganelli G, Chinol M, Maggiolo M, et al. The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy. Eur J Nucl Med. 1997;24:350-351.